These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 489725)

  • 1. Neutralization test in influenza: use in individuals without hemagglutination inhibition antibody.
    Gross PA; Davis AE
    J Clin Microbiol; 1979 Sep; 10(3):382-4. PubMed ID: 489725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of cell-mediated immunity after oral administration of a live influenza vaccine.
    Unanov SS; Yuminova NV; Akopova II
    Acta Virol; 1982 Dec; 26(6):474-80. PubMed ID: 6132541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunogenic activity of the viral hemagglutinin and neuraminidase from live and inactivated influenza vaccines].
    Kustikova IuG; Gagarinova VM; Gorev NE; Shadrin AS
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Apr; (4):79-84. PubMed ID: 6868890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of neuraminidase monospecific (HEqN2) recombinant influenza vaccine in children.
    Beutner KR; Rizzone C; DeMello S; Ogra PL
    Dev Biol Stand; 1976; 33():162-70. PubMed ID: 782964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody response to influenza vaccination in healthy adults.
    Brydak LB; Tadeusz S; Magdalena M
    Viral Immunol; 2004; 17(4):609-15. PubMed ID: 15671759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 1. Short-term immunity.
    Clark A; Potter CW; Jennings R; Nicholl JP; Langrick AF; Schild GC; Wood JM; Tyrrell DA
    J Hyg (Lond); 1983 Jun; 90(3):351-9. PubMed ID: 6863909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody responses to inactivated influenza vaccines and partial protective effect of anti-neuraminidase antibody against epidemics of A(H3N2) and A(H1N1) influenza.
    Maeda A; Oishi I; Minekawa Y; Kunita N; Funahashi S; Yagura H
    Biken J; 1979 Sep; 22(3):91-8. PubMed ID: 533537
    [No Abstract]   [Full Text] [Related]  

  • 8. Reactogenicity and immunogenicity of inactivated influenza A (H1N1) virus vaccine in unprimed children. Report to the Medical Research Council Committee on influenza and other respiratory virus vaccines.
    Potter CW; Clark A; Jennings R; Schild GC; Wood JM; McWilliams PK
    J Biol Stand; 1980; 8(1):35-48. PubMed ID: 6995458
    [No Abstract]   [Full Text] [Related]  

  • 9. Demonstration of antibodies to both hemagglutinin and neuraminidase antigens of H3N2 influenza A virus in domestic dogs.
    Kilbourne ED; Kehoe JM
    Intervirology; 1975-1976; 6(4-5):315-8. PubMed ID: 1235862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactogenicity and immunogenicity of whole and ether-Tween-split influenza A virus vaccines in volunteers.
    Jennings R; Clark A; Oxford JS; Hockley DJ; Potter CW
    J Infect Dis; 1978 Nov; 138(5):577-86. PubMed ID: 712115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Live tissue culture influenza vaccine for oral administration. I. Specific immune response to monovaccine A (H3N2) in volunteers.
    Alekseeva AK; Andzhaparidze OG; Gracheva EN; Sidorova LA; Melnikova SK
    Acta Virol; 1979 Jan; 23(1):59-66. PubMed ID: 35960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response of adults to sequential influenza vaccination.
    Powers RD; Hayden FG; Samuelson J; Gwaltney JM
    J Med Virol; 1984; 14(2):169-75. PubMed ID: 6491643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a neuraminidase-specific influenza A virus vaccine in children: antibody responses and effects on two successive outbreaks of natural infection.
    Beutner KR; Chow T; Rubi E; Strussenberg J; Clement J; Ogra PL
    J Infect Dis; 1979 Dec; 140(6):844-50. PubMed ID: 396336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibody response to hemagglutinin and neuraminidase induced by an influenza subunit vaccine (author's transl)].
    Kuwert E; Werner J; Franke G; Paulus W
    Zentralbl Bakteriol Orig A; 1979 Jun; 244(1):1-16. PubMed ID: 92113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection.
    Monto AS; Petrie JG; Cross RT; Johnson E; Liu M; Zhong W; Levine M; Katz JM; Ohmit SE
    J Infect Dis; 2015 Oct; 212(8):1191-9. PubMed ID: 25858957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of antineuraminidase antibodies in resistance to influenza A and immunologic memory for their synthesis.
    Naikhin AN; Tsaritsina IM; Oleinikova EV; Syrodoeva LG; Korchanova NL; Denisov GM; Shvartsman YaS
    J Hyg (Lond); 1983 Aug; 91(1):131-8. PubMed ID: 6886409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular response in humans following vaccination with Gripax influenza virus.
    Shapira-Nahor O; Morag A; Levy R; Zakay-Rones Z
    J Med Virol; 1982; 10(1):75-80. PubMed ID: 7130968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single-radial haemolysis technique for measurement of antibody to influenza virus neuraminidase in equine sera.
    Gibson CA; Wood JM; Mumford J; Schild GC; Bevan AM
    J Virol Methods; 1985 Aug; 11(4):299-308. PubMed ID: 4055974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral and cell-mediated immune response to influenza virus. II. Experiments in ferrets.
    Semkow R; Loza-Tulimowska M; Brydak L; Zgorzelska K; Wilczyński J; Sadowski W
    Acta Microbiol Pol; 1982; 31(2):195-202. PubMed ID: 6188342
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.